When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective

被引：76

作者：

Huang, S-M ^{[1
]}

Temple, R. ^{[2
]}

Xiao, S. ^{[3
]}

Zhang, L. ^{[1
]}

Lesko, L. J. ^{[1
]}

机构：

[1] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[2] US FDA, Off Med Policy, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[3] US FDA, Div Cardiorenal Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 86卷 / 05期

关键词：

GLOMERULAR-FILTRATION-RATE; IMPACT;

D O I：

10.1038/clpt.2009.190

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

To optimize drug therapy for individuals, it is critical to understand how various intrinsic (e.g., age, gender, race, genetics, organ impairment) and extrinsic factors (e.g., diet, smoking, concomitantly administered drugs) affect drug exposure and response.(1) Up to now, it has been far easier to discover effects on exposure caused by these factors, and the US Food and Drug Administration (FDA) has published several guidance documents with recommendations on how to evaluate these factors during drug development.

引用

页码：475 / 479

页数：6

共 15 条

[1] [Anonymous], 1998, GUID IND PHARM PAT I
[2] Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
Huang, S-M
Temple, R.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 287 - 294
[3] Clinical pharmacology studies in patients with renal impairment: Past experience and regulatory perspectives
Ibrahim, S
Honig, P
Huang, SM
Gillespie, W
Lesko, LJ
Williams, RL
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01) : 31 - 38
[4] A New Equation to Estimate Glomerular Filtration Rate
Levey, Andrew S.
Stevens, Lesley A.
Schmid, Christopher H.
Zhang, Yaping
Castro, Alejandro F., III
Feldman, Harold I.
Kusek, John W.
Eggers, Paul
Van Lente, Frederick
Greene, Tom
Coresh, Josef
[J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 604 - 612
[5] Emerging evidence of the impact of kidney disease on drug metabolism and transport
Nolin, T. D.
Naud, J.
Leblond, F. A.
Pichette, V.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 898 - 903
[6] Continuing the Use of the Cockcroft-Gault Equation for Drug Dosing in Patients With Impaired Renal Function
Spruill, W. J.
Wade, W. E.
Cobb, H. H., III
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) : 468 - 470
[7] Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function
Spruill, William J.
Wade, William E.
Cobb, Henry H., III
[J]. AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2008, 6 (03) : 153 - 160
[8] Use of the MDRD Study Equation to Estimate Kidney Function for Drug Dosing
Stevens, L. A.
Levey, A. S.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) : 465 - 467
[9] Medical progress - Assessing kidney function - Measured and estimated glomerular filtration rate
Stevens, Lesley A.
Coresh, Josef
Greene, Tom
Levey, Andrew S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23) : 2473 - 2483
[10] U.S. Food and Drug Administration, 2006, GUID IND CLIN STUD S

← 1 2 →